Search

Author/Creator Cosenza, Agnese

1. Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab. (8th June 2018)

Authors:
Facchinetti, Francesco; Veneziani, Michele; Buti, Sebastiano; Gelsomino, Francesco; Squadrilli, Anna; Bordi, Paola; Bersanelli, Melissa; Cosenza, Agnese; Ferri, Leonarda; Rapacchi, Elena; Mazzaschi, Giulia; Leonardi, Francesco; Quaini, Federico; Ardizzoni, Andrea; Missale, Gabriele; Tiseo, Marcello
Journal:
Immunotherapy
Issue:
Volume 10:Number 8(2018)
Page Start:
681
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC. (May 2019)

Authors:
Bordi, Paola; Del Re, Marzia; Minari, Roberta; Rofi, Eleonora; Buti, Sebastiano; Restante, Giuliana; Squadrilli, Anna; Crucitta, Stefania; Casartelli, Chiara; Gnetti, Letizia; Azzoni, Cinzia; Bottarelli, Lorena; Petrini, Iacopo; Cosenza, Agnese; Ferri, Leonarda; Rapacchi, Elena; Danesi, Romano; T...
Journal:
Lung cancer
Issue:
Volume 131(2019)
Page Start:
78
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors. Issue 1 (February 2022)

Authors:
Minari, Roberta; Bonatti, Francesco; Mazzaschi, Giulia; Dodi, Alessandra; Facchinetti, Francesco; Gelsomino, Francesco; Cinquegrani, Gloria; Squadrilli, Anna; Bordi, Paola; Buti, Sebastiano; Bersanelli, Melissa; Leonetti, Alessandro; Cosenza, Agnese; Ferri, Leonarda; Rapacchi, Elena; Quaini, Fede...
Journal:
Tumori
Issue:
Volume 108:Issue 1(2022)
Page Start:
47
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search